BRAF-Related In Vivo Models
Discover our comprehensive platform of CDX and PDX tumor models, carrying BRAF mutations across multiple cancer types:
- 18 CDX models carrying BRAF mutation (V600E, G469A, G464V, G466V, G596R or N581Y), covering melanoma, breast cancer, lung cancer and colorectal cancer
- 18 PDX models carrying BRAF mutation (V600E, G469A, G469E, D594N or N581S), covering melanoma, pancreatic cancer, lung cancer, head & neck cancer, colorectal cancer and lymphoma
- Case studies of BRAF and MEK inhibitor evaluation in tumor models carrying Class I, II or III BRAF mutations
BRAF related in vivo models-OncoWuXi Newsletter
Related Content
Antibody-drug conjugates (ADCs) hold great promise as targeted cancer therapeutics, but their complex structure poses significant development and safety challenges....
VIEW RESOURCEIndoleamine 2,3-dioxygenase 1 (IDO1) is an enzyme that metabolizes tryptophan, and its activity can lead to immunosuppression, thereby allowing tumors...
VIEW RESOURCE